Strategic Intelligence on China’s Health Policy, Coverage, and Financing System
Helping life sciences leaders navigate China’s health policy, coverage, and financing complexity for medical technologies — and translate system change into clearer access strategy and better-informed commercial decisions.
Published in Caixin and China Reform Magazine
Share the China access topics you would like covered in the Mid-Year Strategic Debrief and receive a complimentary executive summary in August.
Engagement Paths
Access360
Access360 combines timely interpretation, synthesized strategic outlooks, and member Q&A to help life sciences leaders navigate China access decisions and pressure-test market assumptions across health policy, coverage, financing, and implementation uncertainty.
→ Explore Access360 Membership
China Access Outlook: Strategic Debrief
A mid-year and annual executive synthesis of major developments shaping China’s health policy, pricing, coverage, financing, and adoption environment for medical technologies — helping senior leaders understand what changed, why it matters, and what to watch next.
Available as on-demand executive briefings for standalone purchase or included with Access360 membership.
→ Share Your Perspective — Receive the Complimentary Executive Summary
NRDL+ Masterclass
Executive strategic foundation for China access decision-making.
Through structured interpretation and guided case application, participants connect system-level signals to strategic trade-offs and execution constraints in China’s evolving coverage landscape.